- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Alivus Life Sciences Limited — Important, 11-08-2026: Updates
11-08-2026 | 06:08 pm
11-08-2026 | 06:08 pm
Alivus Life Sciences (formerly Glenmark Life Sciences) reported FY26 turnover of ₹2,552 Cr & net worth of ₹3,332 Cr. A flash fire incident resulted in ₹0.29 Cr environmental compensation. Company progresses towards 2027 water neutrality and 2030 carbon neutrality goals. Noted 47 customer complaints and 2 employee/worker fatalities.
No comments yet. Be the first to comment!